Kaplan-Meier survival curves for the primary and secondary endpoints in the SIERRA-75 prospective cohort.

Download： Full Size Img PowerPoint

Kaplan-Meier survival curves for the primary and secondary endpoints in the SIERRA-75 prospective cohort.

2022, 19(5): 354-366.

Prospective application of a bleeding and ischemic risks-adjusted antithrombotic protocol in elderly patients revascularized with everolimus-eluting stents: EPIC05-Sierra75 study .

Figures of the Article

Flow chart of the study.
Kaplan-Meier survival curves for the primary and secondary endpoints in the SIERRA-75 prospective cohort.
Kaplan-Meier survival curves for the primary and secondary endpoints in the matched SIERRA-75 and CONTROL groups.
Distribution of patients according to different high bleeding risk criteria (A) and bleeding and ischemic risks criteria (B).
Rates of stent thrombosis and bleeding BARC 2-5 according to the duration of DAPT in patients without chronic oral anticoagulation.